Your browser doesn't support javascript.
Ensuring the quality and quantity of personal protective equipment (PPE) by enhancing the procurement process in Northern Ireland during the coronavirus disease 2019 pandemic: Challenges in the procurement process for PPE in NI.
Burnett, Kathryn; Martin, Suzanne; Goudy, Catherine; Barron, John; O'Hare, Linda; Wilson, Peter; Fleming, Glenda; Scott, Michael.
  • Burnett K; School of Pharmacy and Pharmaceutical Sciences,Faculty of Life and Health Sciences, Ulster University, UK.
  • Martin S; Medicines Optimisation Innovation Centre, UK.
  • Goudy C; Regional Pharmaceutical Procurement Service, Northern Health and Social Care Trust, UK.
  • Barron J; Business Services Organisation Procurement and Logistics Service, Health and Social Care Services in Northern Ireland, UK.
  • O'Hare L; Business Services Organisation Procurement and Logistics Service, Health and Social Care Services in Northern Ireland, UK.
  • Wilson P; Business Services Organisation Procurement and Logistics Service, Health and Social Care Services in Northern Ireland, UK.
  • Fleming G; Medicines Optimisation Innovation Centre, UK.
  • Scott M; Medicines Optimisation Innovation Centre, UK.
J Patient Saf Risk Manag ; 27(1): 42-49, 2022 Feb.
Article in English | MEDLINE | ID: covidwho-1518252
ABSTRACT
This article outlines the purchasing process for personal protective equipment that was established for Health and Social Care in Northern Ireland in response to the outbreak of coronavirus disease 2019. The Business Services Organisation Procurement and Logistics Service, who are the sole provider of goods and services for Health and Social Care organisations, was faced with an unprecedented demand for personal protective equipment in response to the coronavirus disease 2019 pandemic. The usual procurement process was further complicated by changing messages within guidelines which resulted in confusion and anxiety when determining whether or not a product would meet the required safety guidance and was therefore suitable for purchase. In order to address these issues in a rapidly changing and escalating scenario the Department of Health asked the Business Services Organisation Procurement and Logistics Service to work with the Medicines Optimisation Innovation Centre to maximise the availability of personal protective equipment whilst ensuring that it met all requisite quality and standards. A process was implemented whereby the Medicines Optimisation Innovation Centre validated all pertinent essential documentation relating to products to ensure that all applicable standards were met, with the Business Services Organisation Procurement and Logistics Service completing all procurement due diligence tasks in line with both normal and coronavirus disease 2019 emergency derogations. It is evident from the data presented that whilst there were a significant number of potential options for supply, a large proportion of these were rejected due to failure to meet the quality assurance criteria. Thus, by the process that was put in place, a large number of unsuitable products were not purchased and only those that met extant standards were approved.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Prognostic study Language: English Journal: J Patient Saf Risk Manag Year: 2022 Document Type: Article Affiliation country: 25160435211057385

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Prognostic study Language: English Journal: J Patient Saf Risk Manag Year: 2022 Document Type: Article Affiliation country: 25160435211057385